Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results-Reference-Cited by-同舟云学术

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results

Published:2014-03-27 Issue:1 Volume:166 Page:109-117
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Jackson Graham H.¹,Morgan Gareth J.²,Davies Faith E.²,Wu Ping²,Gregory Walter M.³,Bell Sue E.³,Szubert Alexander J.³,Navarro Coy Nuria³,Drayson Mark T.⁴,Owen Roger G.⁵,Feyler Sylvia⁶,Ashcroft Andrew J.⁷,Ross Fiona M.⁸,Byrne Jennifer⁹,Roddie Huw¹⁰,Rudin Claudius¹¹,Boyd Kevin D.²,Osborne Wendy L.¹²,Cook Gordon⁵,Child J. Anthony³

Affiliation:

1. University of Newcastle; Newcastle-upon-Tyne UK

2. Institute of Cancer Research; Royal Marsden Hospital; London UK

3. Clinical Trials Research Unit; University of Leeds; Leeds UK

4. University of Birmingham; Birmingham UK

5. St James's University Hospital; Leeds UK

6. Calderdale and Huddersfield NHS Trust; Huddersfield UK

7. Mid Yorkshire Hospitals NHS Trust; Wakefield UK

8. Wessex Regional Genetics Laboratory; University of Southampton; Salisbury UK

9. Nottingham University Hospitals; Nottingham UK

10. Western General Hospital; Edinburgh UK

11. Royal Devon and Exeter Hospital; Exeter UK

12. Freeman Hospital Newcastle; Newcastle-upon-Tyne UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12861/fullpdf

Reference21 articles.

1. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors;Bamias;Journal of Clinical Oncology,2005

2. Guidelines for the diagnosis and management of multiple myeloma 2011;Bird;British Journal of Haematology,2011

3. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid;Dimopoulos;Haematologica,2006

4. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid;Dimopoulos;Annals of Oncology,2009

5. Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement;Durie;Mayo Clinic Proceedings,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence;Clinical and Experimental Medicine;2023-10-07

2. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study;Journal of Stomatology, Oral and Maxillofacial Surgery;2022-11

3. American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update;Journal of Oral and Maxillofacial Surgery;2022-05

4. Small Extracellular Vesicles Derived from Adipose Tissue Prevent Bisphosphonate-Related Osteonecrosis of the Jaw by Promoting Angiogenesis;International Journal of Nanomedicine;2021-05

5. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group;The Lancet Oncology;2021-03